Article Information
History
- September 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Carmela Giachino1,
- Cataldo Tirolo1,
- Salvatore Caniglia1,
- Maria F. Serapide2,
- Francesca L’Episcopo1,
- Federico Bertoli3,4,
- Claudio Giuliano3,4,
- Marika Mearelli3,4,
- Meike Jakobi5,
- Nicole Schneiderhan-Marra5,
- Michela Deleidi3,4,*,# and
- Bianca Marchetti1,2,*,#
- 1OASI-Research Institute-IRCCS, Neuropharmacology Laboratory, Troina-EN-Italy
- 2Biomedical and Biotechnological Sciences, Pharmacology Section, University of Catania-Italy
- 3Mitochondria and Inflammation in Neurodegenerative Diseases, DZNE, Tübingen-Germany
- 4Hertie Institute for Clinical Brain Research, University of Tübingen
- 5NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany
- ↵*Corresponding authors: biancamarchetti{at}libero.it; michela.deleidi{at}dzne.de
Posted September 03, 2022.
LRRK2-G2019S Synergizes with Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation that Precede Nigrostriatal Degeneration
